
Epipole
A UK-based retinal imaging company.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
* | £1.3m Valuation: £7.5m | Seed | |
Total Funding | 000k |
Related Content
Epipole is a pioneering medical devices company specializing in handheld retinal imaging technology. Founded in 2011 by Dr. Craig Robertson, the company operates primarily in the retinal imaging market, serving eyecare practitioners in the UK and the US. Epipole's flagship product, the epiCam, is an ultraportable, high-definition video direct ophthalmoscope designed to improve patient flow and introduce new imaging services. The company aims to eradicate preventable blindness by providing advanced imaging solutions that are easy to use and accessible. Epipole generates revenue through the sale of its imaging devices and offers flexible purchase and support options to make its technology widely accessible. The company leverages its deep roots in optics manufacturing to deliver innovative and reliable products.
Keywords: retinal imaging, handheld devices, ophthalmoscope, eyecare, patient care, UK, US, medical devices, preventable blindness, optics manufacturing.